10-Q/A XBRL

FORM 10-Q/A AMENDED QUARTERLY REPORT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: November 30, 2016
Period of Report: September 30, 2016
Accession Number: 0001078782-16-003875

View Document ↗ View on SEC.gov ↗